世界の自己由来マトリックス誘発軟骨形成市場(材料 – ヒアルロン酸、コラーゲン、ポリエチレングリコール(PEG)、ポリ乳酸 – コ – グリコール酸(PGLA))-グローバル産業分析、規模、シェア、成長、動向及び予測2016-2024

◆英語タイトル:Autologous Matrix-induced Chondrogenesis Market (Material - Hyaluronic Acid, Collagen, Polyethylene Glycol (PEG), and Poly Lactic-Co-Glycolic Acid (PGLA)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
◆商品コード:TMR70221104
◆発行会社(調査会社):Transparency Market Research
◆発行日:2017年2月9日
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,795 ⇒換算¥654,835見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算¥993,835見積依頼/購入/質問フォーム
Corporate LicenseUSD11,795 ⇒換算¥1,332,835見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、世界の自己由来マトリックス誘発軟骨形成市場について調査・分析し、世界の自己由来マトリックス誘発軟骨形成市場規模、市場シェア、成長、市場動向、市場予測、セグメント別市場規模・分析、地域別市場規模・分析、関連企業動向などを含め、以下の構成でお届けいたします。
【レポートの概要】

Global Autologous Matrix-Induced Chondrogenesis Market: Scope and Methodology
This report on the global autologous matrix-induced chondrogenesis market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in this global market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing demand for minimal invasive procedures and increasing prevalence of bone and joint disorder in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Autologous Matrix-Induced Chondrogenesis Market: Segmentation

Based on the material the market has segmented into hyaluronic acid, collagen, polyethylene glycol (PEG), Poly lactic-co-glycolic acid (PGLA) and others segment. Geographically, the global market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.

Autologous Matrix-Induced Chondrogenesis Market: Geographical and Competitive Dynamics

The report also profiles major players in this market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Anika Therapeutics, Inc., Arthro-Kinetics, B. Braun Melsungen AG, BioTissue AG, CartiHeal, Geistlich Pharma AG, JRI Orthopaedics Ltd., Matricel GmbH, Smith & Nephew plc and Zimmer Biomet Holdings.

The global autologous matrix-induced chondrogenesis market has been segmented as follows:

Global Autologous Matrix-Induced Chondrogenesis Market, by Material

Hyaluronic Acid
Collagen
Polyethylene Glycol (PEG)
Poly lactic-co-glycolic acid (PGLA
Others
Global Autologous Matrix-Induced Chondrogenesis Market, by Geography

North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

【レポートの目次】

Section – 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights

Section – 2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global AMIC Market: Market Snapshot
3.2 Global AMIC Market : Opportunity Map

Section-4 Market Overview
4.1 Global AMIC Market : Key Industry Developments

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.1.2 Drivers
5.1.2.1 Increasing Demand for Minimally Invasive Procedures
5.1.2.2 Economically Efficient
5.1.2.3 Rising Prevalence of Bone and Joint Disorders
5.1.2.4 Aging Population
5.1.2.5 Surge in Sports Injuries
5.1.2.6 Reduces Life Risk and Faster Recovery
5.1.3 Restraints
5.1.3.1 Lack of Efficient Reimbursement System
5.1.3.2 Lack of Extensive Clinical Data
5.1.4 Opportunity Analysis
5.1.4.1 Emerging Economies to Offer Sustained Growth Opportunities
5.1.4.2 Extending Distribution Network by Partnership/Acquisitions
5.2 Global AMIC Market Revenue Projection
5.3 Porter’s Five Forces Analysis
5.4 Value Chain Analysis
5.5 AMIC Market Outlook

Section-6 AMIC Market Analysis By Material
6.1 Key Findings
6.2 Introduction
6.3 Global AMIC Market Value Share Analysis, By Product Type
6.4 Global AMIC Market Forecast By Product Type
6.4.1 Hyaluronic Acid
6.4.2 Collagen
6.4.3 Polyethylene glycol (PEG)
6.4.4 Poly lactic-co-glycolic acid (PGLA)
6.4.5 Others
6.5 Global AMIC Market Attractiveness Analysis By Material

Section-7 Global AMIC Market Analysis By Region
7.1 Global Regulatory Scenario
7.2 Global AMIC Market Value Share Analysis, By Region
7.3 Global AMIC Market Forecast, By Region
7.4 Global AMIC Market Attractiveness Analysis, By Region Type

Section-8 North America AMIC Market Analysis
8.1 Key Findings
8.2 North America AMIC Market Overview
8.3 North America Market Value Share Analysis, By Material
8.3.1 North America Market Forecast By Material
8.4 North America Market Forecast By Country
8.5 North America Market Attractiveness Analysis
8.6 North America Market Trends

Section-9 Europe AMIC Market Analysis
9.1 Key Findings
9.2 Europe ABC Market Overview
9.3 Europe Market Value Share Analysis, By Material
9.3.1 Europe Market Forecast By Material
9.4 Europe Market Forecast By Country
9.5 Europe Market Attractiveness Analysis
9.6 Europe Market Trends

Section-10 Asia Pacific AMIC Market Analysis
10.1 Key Findings
10.2 Asia Pacific AMIC Market Overview
10.3 Asia Pacific Market Value Share Analysis, By Material
10.3.1 Asia Pacific Market Forecast By Material
10.4 Asia Pacific Market Forecast By Country
10.5 Asia Pacific Market Attractiveness Analysis
10.6 Asia Pacific Market Trends

Section-11 Latin America AMIC Market Analysis
11.1 Key Findings
11.2 Latin America AMIC Market Overview
11.3 Latin America Market Value Share Analysis, By Material
11.3.1 Latin America Market Forecast By Material
11.4 Latin America Market Forecast By Country
11.5 Latin America Market Attractiveness Analysis
11.6 Latin America Market Trends

Section-12 Middle East and Africa AMIC Market Analysis
12.1 Key Findings
12.2 Middle East and Africa AMIC Market Overview
12.3 Middle East and Africa Market Value Share Analysis, By Material
12.3.1 Middle East and Africa Market Forecast By Material
12.4 Middle East and Africa Market Forecast By Country
12.5 Middle East and Africa Market Attractiveness Analysis

Section-13 Competition Landscape
13.1. Competition Matrix
13.2. Company Profiles
13.2.1. Anika Therapeutics, Inc.
13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.1.2. Financial Overview
13.2.1.3. Product Portfolio
13.2.1.4. SWOT Analysis
13.2.1.5. Strategic Overview
13.2.2 Arthro-Kinetics
13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.2.2. Financial Overview
13.2.2.3. Product Portfolio
13.2.2.4. SWOT Analysis
13.2.2.5. Strategic Overview
13.2.3 B. Braun Melsungen AG
13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.3.2. Financial Overview
13.2.3.3. Product Portfolio
13.2.3.4. SWOT Analysis
13.2.3.5. Strategic Overview
13.2.4 BioTissue AG
13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.4.2. Financial Overview
13.2.4.3. Product Portfolio
13.2.4.4. SWOT Analysis
13.2.4.5. Strategic Overview
13.2.5 CartiHeal
13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.5.2. Financial Overview
13.2.5.3. Product Portfolio
13.2.5.4. SWOT Analysis
13.2.5.5. Strategic Overview
13.2.6 Geistlich Pharma AG
13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.6.2. Financial Overview
13.2.6.3. Product Portfolio
13.2.6.4. SWOT Analysis
13.2.6.5. Strategic Overview
13.2.7 JRI Orthopaedics Ltd.
13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.7.2. Financial Overview
13.2.7.3. Product Portfolio
13.2.7.4. SWOT Analysis
13.2.7.5. Strategic Overview
13.2.8 Matricel GmbH
13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.8.2. Financial Overview
13.2.8.3. Product Portfolio
13.2.8.4. SWOT Analysis
13.2.8.5. Strategic Overview
13.2.9 Smith & Nephew plc
13.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.9.2. Financial Overview
13.2.9.3. Product Portfolio
13.2.9.4. SWOT Analysis
13.2.9.5. Strategic Overview
13.2.10 Zimmer Biomet Holdings
13.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.2.10.2. Financial Overview
13.2.10.3. Product Portfolio
13.2.10.4. SWOT Analysis
13.2.10.5. Strategic Overview

List of Figures

Figure 01: Global Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014–2024
Figure 02: Global AMIC Market Value Share Analysis, by Material, 2016 and 2024
Figure 03: Global Hyaluronic Acid Market Revenue (US$ Mn), 2014–2024
Figure 04: Global Collagen Market Revenue (US$ Mn), 2014–2024
Figure 05: Global PEG Market Revenue (US$ Mn), 2014–2024
Figure 06: Global PGLA Market Revenue (US$ Mn), 2014–2024
Figure 07: Global Others Market Revenue (US$ Mn), 2014–2024
Figure 08: AMIC Market Attractiveness Analysis, by Material
Figure 09: Global AMIC Market Value Share Analysis, by Region, 2016 and 2024
Figure 10: AMIC Market Attractiveness Analysis, by Region
Figure 11: North America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014–2024
Figure 12: North America Autologous Matrix-Induced Chondrogenesis Market Size Y-o-Y Growth Projections, 2015–2024
Figure 13: North America Market Attractiveness Analysis, by Country
Figure 14: North America AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 15: North America AMIC Market Value Share Analysis, by Country, 2016 and 2024
Figure 16: North America Market Attractiveness Analysis, by Material
Figure 17: Europe Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, 2014–2024
Figure 18: Europe Autologous Matrix-Induced Chondrogenesis Market Size Y-o-Y Growth Projections, 2015–2024
Figure 19: Europe Market Attractiveness Analysis, by Country
Figure 20: Europe AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 21: Europe AMIC Market Value Share Analysis, by Country, 2015 and 2024
Figure 22: Europe AMIC Market Attractiveness Analysis, by Material
Figure 23: Asia Pacific AMIC Market Size (US$ Mn) and Forecast, 2014–2024
Figure 24: Asia Pacific AMIC Market Size Y-o-Y Growth Projections, 2015–2024
Figure 25: Asia Pacific Market Attractiveness Analysis, by Country
Figure 26: Asia Pacific AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 27: Asia Pacific AMIC Market Value Share Analysis, by Country, 2015 and 2024
Figure 28: Asia Pacific AMIC Market Attractiveness Analysis, by Material
Figure 29: Latin America AMIC Market Size (US$ Mn) Forecast, 2014–2024
Figure 30: Latin America AMIC Market Size Y-o-Y Growth Projection, 2014–2024
Figure 31: Latin America Market Attractiveness Analysis, by Country/Region
Figure 32: Latin America AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 33: Latin America AMIC Market Value Share Analysis, by Country, 2015 and 2024
Figure 34: Latin America AMIC Market Attractiveness Analysis, by Material
Figure 35: Middle East & Africa AMIC Market Size (US$ Mn) Forecast, 2014–2024
Figure 36: Middle East & Africa AMIC Market Size Y-o-Y Growth Projections, 2015–2024
Figure 37: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 38: Middle East & Africa AMIC Market Value Share Analysis, by Material, 2015 and 2024
Figure 39: Middle East & Africa AMIC Market Value Share Analysis, by Country, 2016 and 2024
Figure 40: Middle East & Africa Market Attractiveness Analysis, by Material
Figure 41: Global Autologous Matrix-Induced Chondrogenesis Market Share Analysis By Company, (2015)

List of Tables

Table 01: Global Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 02: Global Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 03: North America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 04: North America Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 05: Europe Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 06: Europe Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 07: Asia Pacific Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 08: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 09: Latin America Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 10: Latin America Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 11: Middle East & Africa Autologous Matrix-Induced Chondrogenesis Market Size (US$ Mn) Forecast, by Material, 2014–2024
Table 12: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2014–2024

★調査レポート[世界の自己由来マトリックス誘発軟骨形成市場(材料 – ヒアルロン酸、コラーゲン、ポリエチレングリコール(PEG)、ポリ乳酸 – コ – グリコール酸(PGLA))-グローバル産業分析、規模、シェア、成長、動向及び予測2016-2024] (コード:TMR70221104)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の自己由来マトリックス誘発軟骨形成市場(材料 – ヒアルロン酸、コラーゲン、ポリエチレングリコール(PEG)、ポリ乳酸 – コ – グリコール酸(PGLA))-グローバル産業分析、規模、シェア、成長、動向及び予測2016-2024]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆